Berger Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Sell
10,548
-935
-8% -$24.9K 0.02% 376
2025
Q4
$286K Sell
11,483
-3,182
-22% -$80.2K 0.02% 382
2025
Q3
$374K Sell
14,665
-223
-1% -$5.5K 0.02% 318
2025
Q2
$361K Sell
14,888
-1,790
-11% -$41.7K 0.02% 307
2025
Q1
$423K Sell
16,678
-2,925
-15% -$76.5K 0.03% 280
2024
Q4
$520K Sell
19,603
-9,002
-31% -$244K 0.04% 251
2024
Q3
$828K Sell
28,605
-2,351
-8% -$68.6K 0.06% 175
2024
Q2
$866K Buy
30,956
+1,221
+4% +$33.6K 0.07% 163
2024
Q1
$825K Buy
29,735
+4,923
+20% +$137K 0.07% 165
2023
Q4
$714K Sell
24,812
-1,486
-6% -$44.9K 0.07% 141
2023
Q3
$872K Buy
26,298
+5,298
+25% +$187K 0.1% 124
2023
Q2
$770K Buy
21,000
+201
+1% +$7.82K 0.09% 128
2023
Q1
$849K Buy
20,799
+621
+3% +$26.8K 0.1% 118
2022
Q4
$1.03M Buy
20,178
+58
+0.3% +$2.78K 0.14% 105
2022
Q3
$880K Buy
20,120
+292
+1% +$14.2K 0.13% 106
2022
Q2
$1.04M Buy
19,828
+28
+0.1% +$1.43K 0.15% 89
2022
Q1
$1.02M Buy
19,800
+185
+0.9% +$9.6K 0.13% 101
2021
Q4
$1.16M Buy
19,615
+2,773
+16% +$137K 0.15% 93
2021
Q3
$724K Buy
16,842
+775
+5% +$34.3K 0.13% 93
2021
Q2
$629K Buy
16,067
+393
+3% +$15.3K 0.11% 100
2021
Q1
$568K Sell
15,674
-102,086
-87% -$3.62M 0.12% 100
2020
Q4
$4.33M Buy
+117,760
New +$4.32M 0.76% 38

Other funds holding PFE

Berger Financial Group's PFE Position: Q1 2026 in Review

Berger Financial Group reduced its Pfizer (PFE) stake by 8.1% in Q1 2026, selling an estimated $24.9K and leaving 10,548 shares worth $296K. The position accounts for 0.02% of the portfolio, ranked #376.

Berger Financial Group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.33M in Q4 2020. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Berger Financial Group held 10,548 shares of Pfizer worth $296K as of Q1 2026.
  • Berger Financial Group sold 935 Pfizer shares in Q1 2026, an estimated $24.9K.
  • Pfizer made up 0.02% of Berger Financial Group's portfolio in Q1 2026, its #376 holding.
  • Berger Financial Group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Berger Financial Group's Pfizer position peaked at $4.33M in Q4 2020.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Berger Financial Group's 13F filing for Q1 2026, filed 28 Apr 2026.